Frequently Asked Questions about Virbac S.A. (VRBCF)

Name: Virbac S.A. (VRBCF) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Virbac S.A. (VRBCF) do?

Accepted Answer

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides,...

Question 2

Is Virbac S.A. (VRBCF) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of VRBCF reveals an Altman Z-Score of 4.63 and a Piotroski F-Score of 4/9. These metrics, combined with its 5-year revenue trend ($1.46B most recent), help investors decide if VRBCF fits their risk profile.

Question 3

What is the current P/E ratio for VRBCF?

Accepted Answer

As of the latest trading session, Virbac S.A. (VRBCF) has a trailing P/E ratio of 19.37.

Question 4

Who is the CEO of Virbac S.A.?

Accepted Answer

The current Chief Executive Officer of Virbac S.A. is Habib Ramdani.

Question 5

What was VRBCF's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Virbac S.A. reported annual revenues of $1.46B (2025), $1.40B (2024), $1.25B (2023), $1.22B (2022), $1.06B (2021) respectively.

Question 6

Does VRBCF pay a dividend?

Accepted Answer

Virbac S.A. currently pays a dividend to its shareholders, with a trailing dividend yield of 0.42%.

Question 7

How much debt and cash flow does VRBCF have?

Accepted Answer

In its latest reporting period, Virbac S.A. generated $0.10B in Free Cash Flow against a total debt load of $0.30B.

Question 8

What is the Price-to-Book (P/B) ratio of Virbac S.A.?

Accepted Answer

The Price-to-Book (P/B) ratio for Virbac S.A. (VRBCF) is currently 2.60.

Question 9

What is the Price-to-Sales (P/S) ratio of VRBCF?

Accepted Answer

Based on trailing twelve-month data, Virbac S.A. (VRBCF) trades at a Price-to-Sales (P/S) ratio of 1.99.

Question 10

What is Virbac S.A.'s Return on Equity (ROE)?

Accepted Answer

Virbac S.A. (VRBCF) has a Return on Equity (ROE) of 13.78%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	1.5B	517.7M	218.1M	150.8M	17.98
2024-12	1.4B	937.6M	227.5M	145.3M	17.35
2023-12	1.2B	809.6M	184.9M	121.3M	14.38
2022-12	1.2B	795M	179.5M	122M	14.44
2021-12	1.1B	712.9M	167.6M	113.2M	13.40

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	1.5B	517.7M	218.1M	150.8M	17.98
2024-12	1.4B	937.6M	227.5M	145.3M	17.35
2023-12	1.2B	809.6M	184.9M	121.3M	14.38
2022-12	1.2B	795M	179.5M	122M	14.44
2021-12	1.1B	712.9M	167.6M	113.2M	13.40